Home Nucleus Biotechnology U.S. Next Generation Sequencing (NGS) Market to 2032

U.S. Next Generation Sequencing (NGS) Market to 2032

Overview

The U.S. Next Generation Sequencing (NGS) Market is expected to reach a 8,865.90 USD Billion by 2032 and is projected to grow at a CAGR of 26.41% from 2025 to 2032.

Revenue, 2024 (USD Billion)
2,402.91
Forecast, 2032 (USD Billion)
8,865.90
CAGR, 2024 - 2032
26.41%
Report Coverage
U.S.

U.S. Next Generation Sequencing (NGS) Market 2018-2032 USD Billion

U.S. Next Generation Sequencing (NGS) Market, Key Findings (2025-2032)

Market Growth and Projections:

  • Market Size (2024): 2,402.91 USD Billion
  • Projected Market Size (2032): 8,865.90 USD Billion
  • CAGR (2025-2032): 26.41%

Key Findings of U.S. Next Generation Sequencing (NGS) Market

  • The U.S. Next Generation Sequencing (NGS) Market was valued at 8,865.90 USD Billion in 2024.
  • The U.S. Next Generation Sequencing (NGS) Market is likely to grow at a CAGR of 26.41% during the forecast period of 2024 to 2032.
  • In 2024, the Largest segment Precision Medicine in Application Segment accounted for the largest share of the market with a revenue of 2,402.91 USD Billion
  • The fastest growing segment Pharmaceuticals Microbiology in Application Segment grew Fastest with a CAGR of 28.59% during the forecast period from 2024 to 2032.

U.S. Next Generation Sequencing (NGS) Market Scope

U.S. Next Generation Sequencing (NGS) Market Segmentation & Scope
Distribution Channel
  • Others
  • Retail Sales
  • Direct Tender
End User
  • Others
  • Contract Research Organizations (CROS)
  • Clinical Laboratories
  • Hospitals & Clinics
  • Academic & Research Institutes
  • Pharmaceutical & Biotechnology Companies
Application
  • Others
  • Food Pathogen Screening
  • Agricultural & Animal Research
  • Diagnostics
  • Pharmaceuticals Microbiology
  • Precision Medicine
  • Drug & Biomarker Discovery
Technology
  • Others
  • Sequencing By Ligation (SBL)
  • Sequencing By Synthesis (SBS)
Product & Service
  • Instruments
  • Services
  • Consumables

U.S. Next Generation Sequencing (NGS) Market Data Coverage Insights

Study Period 2024-2032
Base Year 2020
Unit Revenue in USD Billion
Market Value in 2024 2,402.91 USD Billion
Market Value in 2032 8,865.90 USD Billion
CAGR (2025-2032) 26.41%
Historic Data 2016-2023
Market Segments Covered Distribution Channel,End User,Application,Technology,Product & Service

Regional Insights:

  • Leading Market (2024-2032): U.S., leading in terms of revenue 2,402.91 USD Billion in 2024
    • Key Country: U.S., leading in terms of revenue with value of 2,402.91 USD Billion in 2024.

Segments and Scope

  • U.S. Next Generation Sequencing (NGS) Market to 2032, By Distribution Channel
    • Direct Tender is the largest segment in U.S. Next Generation Sequencing (NGS) Market to 2032 with a revenue of 1,384.13 USD Billion in the year 2024.
    • Direct Tender is the Fastest growing segment in U.S. Next Generation Sequencing (NGS) Market to 2032 with a Growth rate of 26.79 % in forecast period 2025-2032.
  • U.S. Next Generation Sequencing (NGS) Market to 2032, By End User
    • Pharmaceutical & Biotechnology Companies is the largest segment in U.S. Next Generation Sequencing (NGS) Market to 2032 with a revenue of 838.39 USD Billion in the year 2024.
    • Pharmaceutical & Biotechnology Companies is the Fastest growing segment in U.S. Next Generation Sequencing (NGS) Market to 2032 with a Growth rate of 28.02 % in forecast period 2025-2032.
  • U.S. Next Generation Sequencing (NGS) Market to 2032, By Application
    • Precision Medicine is the largest segment in U.S. Next Generation Sequencing (NGS) Market to 2032 with a revenue of 2,402.91 USD Billion in the year 2024.
    • Pharmaceuticals Microbiology is the Fastest growing segment in U.S. Next Generation Sequencing (NGS) Market to 2032 with a Growth rate of 26.41 % in forecast period 2025-2032.
  • U.S. Next Generation Sequencing (NGS) Market to 2032, By Technology
    • Sequencing By Synthesis (SBS) is the largest segment in U.S. Next Generation Sequencing (NGS) Market to 2032 with a revenue of 1,394.47 USD Billion in the year 2024.
    • Sequencing By Synthesis (SBS) is the Fastest growing segment in U.S. Next Generation Sequencing (NGS) Market to 2032 with a Growth rate of 26.82 % in forecast period 2025-2032.
  • U.S. Next Generation Sequencing (NGS) Market to 2032, By Product & Service
    • Consumables is the largest segment in U.S. Next Generation Sequencing (NGS) Market to 2032 with a revenue of 1,120.34 USD Billion in the year 2024.
    • Services is the Fastest growing segment in U.S. Next Generation Sequencing (NGS) Market to 2032 with a Growth rate of 26.16 % in forecast period 2025-2032.

U.S. Next Generation Sequencing (NGS) Market Company Share Analysis

 
Company Name Company Share Analysis
Merck KGaA
Thermo Fisher Scientific Inc.
QIAGEN
Charles River Laboratories
U.S. Next Generation Sequencing (NGS) Market Company Share Analysis

U.S. Next Generation Sequencing (NGS) Market Geographical Sales Distribution, 2018-2032 USD Billion

U.S. Next Generation Sequencing (NGS) Market Geographical Sales Distribution, 2018-2032 USD Billion

U.S. Next Generation Sequencing (NGS) Market Company Profiling

U.S. Next Generation Sequencing (NGS) Market Company Profiling

Industry Related Reports

South America Cell And Gene Therapy Thawing Equipment Market
Middle East & Africa Cell And Gene Therapy Thawing Equipment Market
North America Cell And Gene Therapy Thawing Equipment Market
Europe Cell And Gene Therapy Thawing Equipment Market
Asia-Pacific Cell And Gene Therapy Thawing Equipment Market
Argentina Cell And Gene Therapy Thawing Equipment Market
Australia Cell And Gene Therapy Thawing Equipment Market
Belgium Cell And Gene Therapy Thawing Equipment Market
Brazil Cell And Gene Therapy Thawing Equipment Market
Canada Cell And Gene Therapy Thawing Equipment Market
Frequently Asked Questions
The U.S. Next Generation Sequencing (NGS) Market is segmented based on Segmentation Distribution Channel,End User,Application,Technology,Product & Service.
U.S. Next Generation Sequencing (NGS) Market was valued at USD 2,402.91(Revenue in USD Billion) in 2020.
U.S. Next Generation Sequencing (NGS) Market is projected to grow at a CAGR of 26.41% during the forecast period of 2024 to 2032.
The Precision Medicine segment is expected to dominate the U.S. Next Generation Sequencing (NGS) Market, holding a largest market share of 2,402.91 USD Billion in 2024

Coming Soon....

U.S. Next Generation Sequencing (NGS) Market Scope

U.S. Next Generation Sequencing (NGS) Market Segmentation & Scope
Distribution Channel
  • Others
  • Retail Sales
  • Direct Tender
End User
  • Others
  • Contract Research Organizations (CROS)
  • Clinical Laboratories
  • Hospitals & Clinics
  • Academic & Research Institutes
  • Pharmaceutical & Biotechnology Companies
Application
  • Others
  • Food Pathogen Screening
  • Agricultural & Animal Research
  • Diagnostics
  • Pharmaceuticals Microbiology
  • Precision Medicine
  • Drug & Biomarker Discovery
Technology
  • Others
  • Sequencing By Ligation (SBL)
  • Sequencing By Synthesis (SBS)
Product & Service
  • Instruments
  • Services
  • Consumables
Frequently Asked Questions
The U.S. Next Generation Sequencing (NGS) Market is segmented based on Segmentation Distribution Channel,End User,Application,Technology,Product & Service.
U.S. Next Generation Sequencing (NGS) Market was valued at USD 2,402.91(Revenue in USD Billion) in 2020.
U.S. Next Generation Sequencing (NGS) Market is projected to grow at a CAGR of 26.41% during the forecast period of 2024 to 2032.
The estimated market value of the U.S. Next Generation Sequencing (NGS) Market for final year is USD 8,865.90 (USD Billion).

U.S. Next Generation Sequencing (NGS) Market Company Profiling

U.S. Next Generation Sequencing (NGS) Market Company Profiling
Frequently Asked Questions
The U.S. Next Generation Sequencing (NGS) Market is segmented based on Segmentation Distribution Channel,End User,Application,Technology,Product & Service.
U.S. Next Generation Sequencing (NGS) Market was valued at USD 2,402.91(Revenue in USD Billion) in 2020.
U.S. Next Generation Sequencing (NGS) Market is projected to grow at a CAGR of 26.41% during the forecast period of 2024 to 2032.
The estimated market value of the U.S. Next Generation Sequencing (NGS) Market for final year is USD 8,865.90 (USD Billion).

Related Markets

HAVE A QUESTION?

Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.